Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by an educational grant from Merck & Co.

Immunotherapy: Advances and Updates

Anthony J. Olszanski, MD, RPH
Fox Chase Cancer Center

Laura J. Zitella, MS, RN, ACNP-BC, AOCN®
Stanford Cancer Institute

One of the greatest advances in oncology over the past decade has been the recognition of cell surface proteins that are shown to play a key role in tumor immunogenicity; mechanisms in which tumors are able to avoid immune surveillance and destruction. Although immunotherapy is a relatively new approach to anti-cancer treatment, it is being utilized across multiple tumor types. This program highlights the science behind immunotherapy, immune-related adverse side effects (irAEs), monitoring and managing irAEs, the role of biomarkers, and differentiating pseudo-progression from actual disease progression.



 

Download Podcast

  
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

  





These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.